BD to Showcase Its Complete Hospital Pharmacy Solutions at the American Society of Health-System Pharmacists’ 2014 Mid-Year Clinical Meeting

“Despite best efforts, patient and healthcare worker safety may still be compromised during the medication distribution process,” said William A. Tozzi, President, BD Medical – Medical-Surgical Systems. “Furthermore, as healthcare continues to evolve, there is a growing demand for better outcomes, while controlling costs through implementing smarter workflow efficiencies. BD’s portfolio of comprehensive hospital pharmacy solutions is specifically designed to address these challenges by improving patient and healthcare worker safety, improving workflow efficiency and helping to facilitate compliance with guidelines and standards in constant evolution. »

The exhibition will provide an experiential view of BD solutions being developed to help tackle the difficult task facing pharmaceutical chief executives to balance quality improvements, worsening legislation changes and drug shortages while continuing to meet cost reduction expectations.

BD’s experiential booth #1101 will feature:

BD Cato™ Drug Workflow Solutions: an automated pharmacy workflow system that detects erroneous dose/medication errors in real time, standardizes workflow for medication preparations, automates documentation, and optimizes medication usage to reduce medication waste. The system provides a robust interface with pharmacy IT systems to automatically pull medication orders and enable dose queue management within the compounding environment, and provides a range of reports and analytics to help improve safety and efficiency. This year, BD will introduce a new camera-based visual documentation system ahead of its launch in February 2015which will allow remote verification of doses and documentation of images.

BD Diabetes Care and AutoShield Duo™: BD AutoShield Duo Pen Needle is the only safety pen needle in the United States that provides passive front and back needle protection to reduce the risk of accidental needlestick injuries , and supports the current AADE practice advisory for injection technique guidelines calling for the use of shorter needles, proper site rotation, and single-use needle use. For 90 years, BD’s culture of innovation and continuous improvement has enhanced the patient experience to help improve treatment and outcomes for people with diabetes around the world.

BD Disposal Solutions: are specially designed collectors to safely contain sharps, non-hazardous pharmaceutical, chemotherapy and hazardous RCRA waste. Collectors are available in a variety of colors and sizes to meet disposal needs and are safe for incineration.

BD Enteral Syringe with BD UniVia™ Connector: is designed to reduce the risk of tubing misconnection, which can lead to medication errors. This helps in the safe delivery of food and oral medications.

BD Drug Preparation Products: including BD™ Filter and BD Nokor™ Needles, BD Convenience Sterile Syringe Trays, BD Cap Trays, BD Oral Syringe System and BD PosiFlush™ Prefilled Syringes are designed to improve the preparation and dispensing process. drug administration.

BD PhaSeal™ System: a closed-circuit drug transfer device (CSTD) that reduces exposure of healthcare workers to hazardous parenteral drugs, from compounding in the pharmacy to administration with the patient. The BD PhaSeal System is an airtight, leak-tight CSTD that mechanically prohibits the transfer of environmental contaminants into the system and the escape of drug concentrations or vapors outside the system, thereby minimizing personal exposure and environmental exposure to aerosols and drug vapor spills. The system also prevents microbial penetration. With a limited number of components and a single connection interface, the dimensions of the BD PhaSeal System are created according to ISO standards to be compatible with all standard size drug bottles and tubing.

BD Simplist™ Prefilled Injectables: are ready-to-use, prefilled injectables designed to reduce the potential risk of medication error. Individually packaged, clearly labeled and barcoded ready-to-administer (RTA) injectables enable compliance with Joint Commission drug management standards.

Intelliport® system: a medication management solution for manual IV bolus injections that automatically identifies IV injection medication name and strength, performs real-time allergy checks before an injection, measures the cumulative dose delivered to a patient during an injection, and wirelessly sends captured medication/dose/time information directly to the patient’s electronic medical record following an injection. The Intelliport® system is currently under review by the FDA. Intelliport is a trademark of CRISI Medical Systems, Inc.

For more information, visit

About comics
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world’s most pressing and evolving healthcare needs. Our innovative solutions are focused on improving drug delivery, improving the diagnosis of infectious diseases and cancers, supporting diabetes management and advancing cellular research. We are more than 30,000 associates in 50 countries working to achieve our goal of “Helping all people live healthy lives” by advancing the quality, accessibility, safety and affordability of care health around the world. For more information, visit

Matt Coppola
Public relations
(201) 847-7370
[email protected]

Photo –

To view the original version on PR Newswire, visit: -mid-year-clinical-meeting-300006108.html of health system pharmacists

COMIC SOURCE (Becton, Dickinson and Company)

Related links

Comments are closed.